“Brain booster” is a marketing term, not a precise medical effect. Anyone considering Brahmi for memory or concentration should know which tasks were actually tested. Improvement on one test does not automatically mean a noticeable increase in every aspect of mental performance.
What an older controlled study found
In 2008, Calabrese and colleagues investigated a standardized Bacopa extract in people aged 65 and older without clinical dementia. Of 54 randomized participants, 48 completed the twelve-week study. Benefits appeared in delayed recall and the Stroop test, but not other tests. Stomach complaints were also reported. The findings concern this preparation and population. [1]
The 2025 trial adds a different picture
Lopresti and Smith randomly assigned 101 adults with self-reported memory or attention problems to a Bacopa extract or placebo. Eighty-seven completed twelve weeks. There were no group differences on the primary tests of verbal learning, attention and working memory. Some secondary reports of stress and task-related fatigue improved. More adverse events occurred with Bacopa, particularly digestive complaints and headaches. [2]
A fair assessment does not omit less favorable results. Conversely, one negative trial does not prove that every possible preparation must be ineffective in everyone. These studies do not support a universal performance promise.
| Checkpoint | Why it matters |
|---|---|
| Participants | Healthy adults and people with diagnosed dementia are not the same population. |
| Preparation | A particular extract is not equivalent to every powder or blend. |
| Duration | Twelve weeks does not answer questions about years of prevention. |
| Outcomes | Distinguish primary tests, secondary reports and everyday impressions. |
Why secondary results do not replace the main finding
When many different outcomes are assessed, it must be clear which question was originally central. A positive secondary aspect can be interesting, but must not conceal failure to confirm the main goal. A statistical difference does not automatically mean an important everyday change either.
A hypothetical example: someone remembers a shopping list more easily while also sleeping better and repeatedly practicing the same test. This is an observation, not clear evidence for the preparation just started.
Take safety and symptoms seriously
The cited studies are not instructions for self-treating dementia, ADHD or depression. New or increasing memory problems should not be addressed solely with a supplement. With medicines and existing conditions, bring the complete formulation to a professional consultation. Commercial products and study preparations can differ. [3]
Frequently asked questions
Are there positive Bacopa studies?
Yes. Some controlled investigations found benefits on particular tests.
Did the 2025 trial confirm the primary memory goals?
No. The cited primary tests did not differ between groups.
Does this establish less dementia later in life?
Such long-term disease outcomes were not demonstrated here.
Are adverse effects excluded?
No. Unwanted events were also recorded in the studies discussed.
Read more: Comparing Brahmi extracts and daily servings and Understanding Bacopa botanically.
Sources
[1] Calabrese et al., Journal of Alternative and Complementary Medicine, 2008, PMID 18611150. [2] Lopresti and Smith, Clinical Drug Investigation, 2025, PMID 41091332. [3] NCCIH: Using Dietary Supplements Wisely. Sources linked in the text; editorial review: September 29, 2026. Not individual treatment advice.
